Article by Evestra Evestra team published in prestigious journal

Lodz, 05.09.2023 – Evestra Onkologia is pleased and honoured to announce the publication of its latest scientific article in the renowned endocrinology journal Frontiers in Endocrinology (IF=5.2/2022). The article titled ” Next Step in the Development of Mesoprogestins: The Preclinical Profile of EC313” by Katarzyna Blaszczak-Swiątkiewicz et al. was published in the second most cited endocrinology journal.

The article describes the preclinical part of the development program of a mesoprogestins drug candidate that is the only one in its class. The paper presents the results of the numerous in vitro and in vivo studies conducted, including pharmacodynamics.

The publication in one of the most cited endocrinology journals underscores the importance of scientific achievements in the pursuit of further development of EC313 with an indication for the treatment of endocrine malignancies underlying the development of endometriosis.

Interested parties can read the full article on the journal’s website or visit our website to learn more about our research and commitment to endometriosis treatment.

Website designed and made by Reddog Systems